
USFDA APPLICATION NUMBER - 21567 / DOSAGE - CAPSULE;ORAL - EQ 200MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| ATAZANAVIR SULFATE(UNII: 4MT4VIE29P) (ATAZANAVIR - UNII:QZU4H47A3S) | ATAZANAVIR | 200mg | 300mg |
Inactive Ingredients
| Ingredient Name | A-S Medication Solutions | A-S Medication Solutions LLC | Cipla USA Inc. | Greenstone LLC | REMEDYREPACK INC. | Aurobindo Pharma Limited | NorthStar Rx LLC | American Health Packaging | Golden State Medical Supply Inc. | Major Pharmaceuticals |
|---|---|---|---|---|---|---|---|---|---|---|
| ALCOHOL(3K9958V90M) | ||||||||||
| AMMONIA(5138Q19F1X) | ||||||||||
| BUTYL ALCOHOL(8PJ61P6TS3) | ||||||||||
| CROSPOVIDONE (120 .MU.M)(68401960MK) | ||||||||||
| CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK) | ||||||||||
| CROSPOVIDONE(2S7830E561) | ||||||||||
| CROSPOVIDONE(68401960MK) | ||||||||||
| D&C YELLOW NO. 10(35SW5USQ3G) | ||||||||||
| FD&C BLUE NO. 1(H3R47K3TBD) | ||||||||||
| FD&C BLUE NO. 2(L06K8R7DQK) | ||||||||||
| FD&C RED NO. 3(PN2ZH5LOQY) | ||||||||||
| FD&C RED NO. 4(X3W0AM1JLX) | ||||||||||
| FD&C RED NO. 40(WZB9127XOA) | ||||||||||
| FERRIC OXIDE RED(1K09F3G675) | ||||||||||
| FERRIC OXIDE YELLOW(EX438O2MRT) | ||||||||||
| FERROSOFERRIC OXIDE(XM0M87F357) | ||||||||||
| GELATIN(2G86QN327L) | ||||||||||
| GELATIN, UNSPECIFIED(2G86QN327L) | ||||||||||
| ISOPROPYL ALCOHOL(ND2M416302) | ||||||||||
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | ||||||||||
| MAGNESIUM STEARATE(70097M6I30) | ||||||||||
| POTASSIUM HYDROXIDE(WZH3C48M4T) | ||||||||||
| PROPYLENE GLYCOL(6DC9Q167V3) | ||||||||||
| SHELLAC(46N107B71O) | ||||||||||
| SODIUM LAURYL SULFATE(368GB5141J) | ||||||||||
| SORBITAN MONOLAURATE(6W9PS8B71J) | ||||||||||
| TITANIUM DIOXIDE(15FIX9V2JP) |